ISPOR Press Pass Information

ISPOR—the professional society for health economics and outcomes research—invites credentialed journalists to cover its scientific conferences and events.

Press passes are available for journalists and correspondents representing newspapers, news programs, industry newsletters, and business publications that operate within the scope of ISPOR's mission and objectives. Some examples include, but are not limited to:

PM360 | AJMC | The Gold Sheet  |  PharmAsia News  |  The Gray Sheet  |  The Pink Sheet  |  The Silver Sheet  |  BioPharm Insight  |  Health News Daily |  Politico Pro Healthcare  |  Pharmaceutical Approvals Monthly  |  APM Health Europe  |  Medtech Insight  |  Health 2.0 Latin America

ISPOR Press Passes are reserved for working media engaged in reporting and distributing information directly to the general public.

Representation from peer-reviewed scientific journals, other society publications, independent consulting firms, sales, advertising, public relations, marketing firms, or conference exhibitors are not eligible for Press Passes.

ISPOR Press Pass Benefits

An ISPOR Press Pass entitles the recipient to one complimentary registration to attend the ISPOR Real-World Evidence Summit 2024 on 17 November 2024.

ISPOR Press Pass Application Deadline for the ISPOR Real-World Evidence Summit 2024 is 1 November 2024.

To apply for a press pass, email ISPOR Communications.

ISPOR will contact you to confirm your request and to provide further information.

Members of the media are requested to send ISPOR examples of their coverage after the event. We ask that the event name and date be appropriately credited (e.g., "from ISPOR Real-World Evidence Summit 2024 held 17 November 2024 in Barcelona, Spain”) in all media coverage, including print news stories, e-newsletters, web postings, blogs, and/or video coverage. The first reference to ISPOR should be written as "ISPOR—The Professional Society for Health Economics and Outcomes Research, " after which ISPOR can be used. All print, broadcast, and electronic media clips/write-ups, etc., should be sent to ISPOR Communications at ISPOR does not share, rent, or distribute media registration information.

ISPOR supports the promotion of research presented at its conferences, while safeguarding sensitive information, data, and research findings that are not yet available to the public. Due to the sensitive and preliminary nature of data and unpublished research findings, all filming (photos + video) and recording of scientific sessions is prohibited during the conference/event. Conference/event attendees must gain approval from the speakers prior to quoting or publishing that individual's scientific results. Members of the press must identify themselves as such before questioning speakers and attendees if using the information in a professional capacity.

Summit Name: ISPOR Real-World Evidence Summit 2024
Summit Hashtag: #ISPORSummit
When Referencing “ISPOR” in writing:
First reference: “ISPOR—The Professional Society for Health Economics and Outcomes Research”
Second+ reference: “ISPOR"

Press Kit

ISPOR's Embargo and Legal policies must be noted

ISPOR Embargo Policy

Contributed research presenters at ISPOR conferences who are issuing press releases relating to their contributed research presentation are required to abide by the following ISPOR Press Release Embargo Policy.

For Contributed Research Presentations at ISPOR Conferences:

Promotion of general topics, speakers, or presentation times is permitted and encouraged within the stated guidelines.

  • For press releases referring ONLY to information contained in the contributed research abstract, [ie, information limited to OBJECTIVES, METHODS, RESULTS, and CONCLUSIONS of the abstract], all information is embargoed until the abstract has been published to the ISPOR conference program at or to the ISPOR Presentations Database.
  • For press releases referring to information which goes beyond that contained in the contributed research abstract [ie, OBJECTIVES, METHODS, RESULTS, and CONCLUSIONS of the abstract] such as additional analysis, commentary, or updated information from those individuals and companies involved in the study, the information is embargoed until it has been presented at the specific ISPOR conference to which it was submitted and accepted. Presented research abstracts will be published online in Value in Health or Value in Health Regional Issues after the conference.

Legal Disclaimer

ISPOR—the professional society for health economics and outcomes research ("ISPOR" or "Society")—is providing information and services on the Internet through its website as a benefit and service in furtherance of its nonprofit and tax exempt status under Section 501(c)(3) of the Internal Revenue Code. ISPOR does not endorse, approve, guarantee, or certify that any information posted by ISPOR or third parties is accurate, complete, timely, or effective. Use of such information is entirely voluntary and reliance on it should only be undertaken after an independent review of it by qualified experts.

Any posting, electronic or related discussions, or other conduct or activities must comply with all applicable laws and ISPOR standards, policies, and procedures. Although the ISPOR website may include links providing direct access to other Internet sites, the Society has not participated in the development of those other sites, and does not exert any editorial or other control over those other sites.

The ISPOR website is created and controlled by ISPOR in New Jersey, USA. As such, the laws of New Jersey shall govern these disclaimers and terms and conditions of use and any conflict that may arise in connection with this website without reference to any principles of conflicts of laws. Jurisdiction and venue for all such conflicts arising in connection with this website shall be in the state or federal courts of New Jersey.

The ISPOR logo is the property of ISPOR—the professional society for health economics and outcomes research—and cannot be used without the expressed written consent of ISPOR.

Any questions about these policies should be directed to ISPOR Communications at